Vapo Health, a China medical device company specializing in nebulizers, completed a Series A financing led by CCB International. Although the specific amount was not disclosed, it was reported to be in the “millions of dollars” range. Vapo offers a nano-scale atomized micro-hole technology to ensure consistent particle size. Formed in 2015, the company launched its first product in 2018. Vapo is already one of the top three dealers in Germany and Italy and exports its products to 14 countries, especially EU and US markets. Vapo is located in Kunshan, Jiangsu Province. Source: China Biotoday
